These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 29226402)

  • 1. Letter: biologics treatment in Crohn's disease and risk of bowel resection-what about the patients who stop anti-TNF therapy? Authors' reply.
    Eberhardson M; Söderling JK; Olén O
    Aliment Pharmacol Ther; 2018 Jan; 47(1):147-148. PubMed ID: 29226402
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter: biologics treatment in Crohn's disease and risk of bowel resection-what about the patients who stop anti-TNF therapy?
    Ribaldone DG; Saracco G; Astegiano M; Pellicano R
    Aliment Pharmacol Ther; 2018 Jan; 47(1):146-147. PubMed ID: 29226397
    [No Abstract]   [Full Text] [Related]  

  • 3. Letter: should we delay surgery, or stop anti-TNF therapy prior to elective surgical procedures in Crohn's disease patients receiving anti-TNF agents? Authors' reply.
    Lin YS; Chen MJ; Lin WC; Wang YH; Chen C
    Aliment Pharmacol Ther; 2019 Oct; 50(8):970-971. PubMed ID: 31591780
    [No Abstract]   [Full Text] [Related]  

  • 4. A review of the impact of biologics on surgical complications in Crohn's disease.
    Chang MI; Cohen BL; Greenstein AJ
    Inflamm Bowel Dis; 2015 Jun; 21(6):1472-7. PubMed ID: 25811432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Letter: accuracy of magnetic resonance index of activity score to predict response to biologics in Crohn's disease-authors' reply.
    Rimola J; Panés J; Ordás I
    Aliment Pharmacol Ther; 2021 Jan; 53(1):207-208. PubMed ID: 33333609
    [No Abstract]   [Full Text] [Related]  

  • 6. Letter: choosing between ustekinumab and vedolizumab in anti-TNF refractory Crohn's disease-the devil is in the detail. Authors' reply.
    Alric H; Amiot A; Carbonnel F; Meyer A
    Aliment Pharmacol Ther; 2020 Aug; 52(3):563-564. PubMed ID: 32656831
    [No Abstract]   [Full Text] [Related]  

  • 7. Tumor necrosis factor-alpha antibody for maintenance of remission in Crohn's disease.
    Behm BW; Bickston SJ
    Cochrane Database Syst Rev; 2008 Jan; (1):CD006893. PubMed ID: 18254120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Letter: pre-operative anti-TNF therapy in Crohn's disease is not associated with increased complications following elective surgery. Authors' reply.
    Lin YS; Chen MJ; Lin WC; Wang YH; Chen C
    Aliment Pharmacol Ther; 2019 Aug; 50(4):469-470. PubMed ID: 31359468
    [No Abstract]   [Full Text] [Related]  

  • 9. Management of post-operative Crohn's disease in 2017: where do we go from here?
    Nguyen V; Kanth R; Gazo J; Sorrentino D
    Expert Rev Gastroenterol Hepatol; 2016 Nov; 10(11):1257-1269. PubMed ID: 27678049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Letter: anti-TNF therapy and intestinal resections in Crohn's disease-are we just delaying the inevitable?
    Ashton JJ; Beattie RM
    Aliment Pharmacol Ther; 2019 Oct; 50(7):842-843. PubMed ID: 31532558
    [No Abstract]   [Full Text] [Related]  

  • 11. Letter: biologics are effective in neutralising the detrimental effect of smoking on the natural course of Crohn's disease - authors' reply.
    To N; Gracie DJ; Ford AC
    Aliment Pharmacol Ther; 2016 Jun; 43(11):1246. PubMed ID: 27137735
    [No Abstract]   [Full Text] [Related]  

  • 12. Surgery for Crohn's disease and anti-TNF agents: the changing scenario.
    Sorrentino D; Fogel S; Van den Bogaerde J
    Expert Rev Gastroenterol Hepatol; 2013 Nov; 7(8):689-700. PubMed ID: 24161133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Letter: should immunosuppressive therapy be started with adalimumab in Crohn's disease? Authors' reply.
    Reenaers C; Louis E; Belaiche J; Seidel L; Keshav S; Travis S
    Aliment Pharmacol Ther; 2013 Apr; 37(7):752-3. PubMed ID: 23458531
    [No Abstract]   [Full Text] [Related]  

  • 14. Anoperineal lesions in Crohn's disease: French recommendations for clinical practice.
    Bouchard D; Abramowitz L; Bouguen G; Brochard C; Dabadie A; de Parades V; Eléouet-Kaplan M; Fathallah N; Faucheron JL; Maggiori L; Panis Y; Pigot F; Rouméguère P; Sénéjoux A; Siproudhis L; Staumont G; Suduca JM; Vinson-Bonnet B; Zeitoun JD
    Tech Coloproctol; 2017 Sep; 21(9):683-691. PubMed ID: 28929282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparable outcomes of the consistent use versus switched use of anti- tumor necrosis factor agents in postoperative recurrent Crohn's disease following ileocolonic resection.
    Li Y; Stocchi L; Rui Y; Remzi FH; Shen B
    Int J Colorectal Dis; 2016 Nov; 31(11):1751-1758. PubMed ID: 27475090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies.
    Magro F; Portela F
    BioDrugs; 2010 Dec; 24 Suppl 1():3-14. PubMed ID: 21175228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effectiveness of anti-TNF alpha antibodies in treatment of fistulizing Crohn's disease].
    Rozpondek P; Zwolińska-Wcisło M; Przybylska M; Mach T
    Przegl Lek; 2011; 68(9):602-5. PubMed ID: 22335009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concomitant therapy with methotrexate and anti-TNF-α in pediatric patients with refractory crohn's colitis: a case series.
    Absah I; Faubion WA
    Inflamm Bowel Dis; 2012 Aug; 18(8):1488-92. PubMed ID: 21882301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Letter: when to withhold anti-TNF agents prior to abdominal surgery in patients with Crohn's disease-the jury might still be out. Authors' reply.
    Lin YS; Lin WC; Chen MJ; Wang YH; Chen C
    Aliment Pharmacol Ther; 2019 Aug; 50(4):465-466. PubMed ID: 31359483
    [No Abstract]   [Full Text] [Related]  

  • 20. Distinctive histopathologic phenotype in resection specimens from patients with Crohn's disease receiving anti-TNF-α therapy.
    Schaeffer DF; Walsh JC; Kirsch R; Waterman M; Silverberg MS; Riddell RH
    Hum Pathol; 2014 Sep; 45(9):1928-35. PubMed ID: 25022570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.